Detalles de la búsqueda
1.
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
J Infect Dis
; 228(6): 715-722, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202147
2.
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
PLoS Med
; 19(5): e1003953, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617368
3.
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
J Virol
; 95(4)2021 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219167
4.
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
J Infect Dis
; 222(5): 746-754, 2020 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32563194
5.
Outbreak of Vaccinia Virus Infection from Occupational Exposure, China, 2017.
Emerg Infect Dis
; 25(6): 1192-1195, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31107220
6.
Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producing Escherichia coli strains by a time-resolved fluorescence immunoassay.
Luminescence
; 33(3): 574-581, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29350441
7.
Identification and genetic characterization of a novel circular single-stranded DNA virus in a human upper respiratory tract sample.
Arch Virol
; 162(11): 3305-3312, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28707271
8.
Development and application of a one-step real-time RT-PCR using a minor-groove-binding probe for the detection of a novel bunyavirus in clinical specimens.
J Med Virol
; 85(2): 370-7, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23212930
9.
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18-59 Years and over 60 Years Based on Two Randomized Controlled Trials in China.
Vaccines (Basel)
; 11(12)2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140219
10.
Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial.
Expert Rev Vaccines
; 22(1): 662-670, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432025
11.
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.
Emerg Microbes Infect
; 12(1): 2155251, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36503413
12.
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.
Lancet Respir Med
; 11(7): 613-623, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898400
13.
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial.
Lancet Reg Health West Pac
; : 100829, 2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37360864
14.
Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay.
J Clin Microbiol
; 50(2): 372-7, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22135253
15.
Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization.
J Clin Microbiol
; 50(12): 3881-5, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22993179
16.
Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection.
BMC Infect Dis
; 12: 384, 2012 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23272999
17.
Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature.
Food Environ Virol
; 14(1): 101-104, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35084667
18.
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial.
Nat Med
; 28(2): 401-409, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087233
19.
Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial.
Adv Ther
; 39(8): 3789-3798, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771353
20.
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial.
Lancet Respir Med
; 10(8): 739-748, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35605625